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Abstract
Aims: The aim of the study was to assess the feasibility and accuracy of an integrated stress imaging
algorithm with echo first and second-line Cardiac Magnetic Resonance (CMR) in selected cases.
Stress echo (SE) is widely used for non-invasive diagnosis of coronary artery disease (CAD), but
difficult patients and ambiguous responses may be met even with top-level technology and
expertise. CMR might ideally complement SE in well-selected cases with unfeasible and/or
ambiguous and/or submaximal results.
Methods and results: 152 in-hospital patients with chest pain and normal baseline function were
referred for SE and coronary angiography. Of the initial population, 33 were shunted to CMR due
to poor acoustic window or ambiguous or submaximal SE test. The only criterion of positivity for
both techniques was the presence of regional wall motion abnormalities in at least 2 contiguous
segments. Coronary angiography was performed independently of test results. Significant CAD was
identified by a >50% quantitatively assessed diameter reduction in at least 1 major coronary vessel.
CAD was present in 88 patients. Interpretable and diagnostic stress test were obtained in 143
patients with the sequential algorithm. The sequential (SE in 110 + CMR in 33 patients) algorithm
showed a sensitivity of 76% (95% CI 66% to 85%) specificity of 87% (95% CI 76% to 95%) and
accuracy of 80% (95% CI 73% to 86%).
Conclusion: A sequential functional stress imaging algorithm with stress echo first and stress CMR
in selected cases is feasible, clinically realistic and allows an efficient, radiation-free diagnosis of
CAD.
Background
Stress echocardiography is an established cost-effective
technique for the detection of coronary artery disease [1].
According to the guidelines of European Society of Cardi-
ology and American Society of Echocardiography – stress
echocardiography (with exercise, dobutamine or dipyri-
damole) is a class I indication (of documented effective-
ness and usefulness) for the diagnosis of coronary artery
disease and for the prognostic stratification of patients
with known coronary artery disease [2,3]. The widespread
use in the clinical practice has become possible only after
evidence collected through large scale multicenter studies
Published: 4 December 2007
Cardiovascular Ultrasound 2007, 5:47 doi:10.1186/1476-7120-5-47
Received: 26 October 2007
Accepted: 4 December 2007
This article is available from: http://www.cardiovascularultrasound.com/content/5/1/47
© 2007 Sicari et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cardiovascular Ultrasound 2007, 5:47 http://www.cardiovascularultrasound.com/content/5/1/47
Page 2 of 7
(page number not for citation purposes)
that demonstrated its feasibility, safety, diagnostic and
prognostic accuracy [4-9]. Its major limitation is related to
a high inter-observer variability and to operator-depend-
ent expertise that might be overcome by an appropriate
training and the use of strict reading criteria [10-12].
Moreover, a percentage, although small, of patients is not
feasible for echo scanning due to an acoustically hostile
window (chronic obstructive pulmonary disease, confor-
mation of the thorax etc.). Cardiac magnetic resonance
(CMR) is the latest technique entering the field of cardiac
imaging [13-16]. The advantages of the technique are
related to its less pronounced operator-independence and
the absence of ionising radiation, at the price of higher
costs and lower availability when compared with echocar-
diography. Therefore, CMR might represent a good alter-
native to stress echocardiography when the latter is not
feasible or test result is ambiguous. The aim of the study
was to assess the feasibility and accuracy of an integrated
algorithm with stress echo first and second-line stress
CMR in selected cases.
Methods
Patients
Starting January 2003, from the data bank of the Institute
of Clinical Physiology, 143 (101 males; 64 ± 9 years) non-
consecutive in-hospital patients or outpatients referred to
the stress echocardiography laboratory for evaluation of
chest pain, or patients with known coronary artery dis-
ease, or both were enrolled in the study. Exclusion criteria
were congestive heart failure, unstable angina, docu-
mented cardiomyopathy and previous myocardial infarc-
tion. All patients underwent quantitative coronary
angiography independently of test result and within 1
week of testing. Of the initial population of 152 who were
referred for stress echocardiography (exercise in 110 and
dipyridamole in 42), 3 had a poor acoustic window, 1 had
an ambiguous response, 29 had a submaximal exercise
stress echo test, and in 4 dipyridamole was prematurely
interrupted due to side effects (Fig. 1). Four patients who
experienced side effects during dipyridamole stress
echocardiography were referred to dobutamine stress
echocardiography. The remaining 35 patients were
referred to the magnetic resonance laboratory to undergo
dipyridamole CMR stress test. Of them 1 did not fit into
MR bore and 1 was not imaged because of claustrophobic
reaction. The study was approved by the Institutional
review board. The final patient population consisted of
143 patients who were included in the accuracy analysis.
The pretest likelihood of coronary artery disease was esti-
mated from age, sex and symptoms [17]; patients with
known coronary artery disease were assigned a value of
100%. The estimated likelihood of coronary artery disease
was less than 50% in 9 patients (6%), 50% to 80% in 43
patients (30%), and greater than 80% in 91 patients
(64%). According to individuals needs and physician's
choices, 84 patients were evaluated after anti-anginal
drugs had been discontinued, and 59 patients were evalu-
ated during anti-anginal treatment (nitrates and/or cal-
cium antagonists and/or beta-blockers). All patients gave
their written informed consent when they underwent
stress echocardiography. When patients signed the written
informed consent they also authorized physicians to use
their clinical data. Stress echo and CMR data were col-
lected and analysed by physicians not involved in patient
care.
Stress protocols
Two-dimensional echocardiography and 12-lead electro-
cardiographic (ECG) monitoring were performed in com-
bination with high dose dipyridamole (up to 0.84 mg
over 6 min) or with semi-supine exercise ECG in accord-
ance to well established protocols [18-20]. Cardiac mag-
netic resonance was performed in combination with high
dose dipyridamole with the same dose used for stress echo
[18,19]. During the procedure, blood pressure and ECG
were recorded each minute.
The proposed sequential algorithm Figure 1
The proposed sequential algorithm.
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Echocardiographic analysis
Two-dimensional echocardiographic monitoring was per-
formed throughout and up to 5 min after the end of peak
stress. Two-dimensional images were recorded at baseline
and at the end of each step. Regional wall motion analysis
was evaluated at baseline and at peak stress with a semi-
quantitative assessment of a wall motion score index
(WMSI), with the 17 segment model of the left ventricle,
each segment ranging from 1 = normal/hyperkinetic to 4
= dyskinetic, according to the recommendations of the
American Heart Association and American Society of
Echocardiography [21,22]. WMSI was derived by dividing
the sum of individual segment scores by the number of
interpretable segments [18]. Test positivity was defined as
the occurrence of at least one of the following conditions:
1) new dyssynergy in a region with normal rest function
(i.e., normokinesia becoming hypokinesia, akinesia or
dyskinesia) in at least two adjacent segments. Non-
echocardiographic test end-points were the following:
peak dipyridamole dose; 85% of target heart rate; achieve-
ment of conventional end-points (such as severe chest
pain and/or diagnostic ST segment changes). The test was
also stopped, in the absence of diagnostic endpoints, for
one of the following reasons of constituting a submaxi-
mal, non-diagnostic test: intolerable symptoms; limiting
asymptomatic side effects, consisting of: a) hypertension
(systolic blood pressure >220 mmHg; diastolic blood
pressure >120 mmHg); b) hypotension (relative or abso-
lute): >30 mmHg fall of blood pressure; c) supraventricu-
lar arrhythmias: supraventricular tachycardia or atrial
fibrillation; d) ventricular arrhythmias: ventricular tachy-
cardia; frequent, polymorphous premature ventricular
beats.
Magnetic resonance analysis
CMR has been performed on a whole body MR scanner
(Signa Cvi, GE, USA), operating at 1.5T by using a dedi-
cated cardiac 8 elements phased-array coil. CMR acquisi-
tion has been performed according to a standardized
protocol. Cardiac images have been obtained using a
breath-hold segmented gradient echo Steady State Free
Precession (SSFP) electrocardiographic triggered
sequences. The echo time was 1.7 ms; repetition time 4.0
ms; slice thickness 8 mm with no interslice gap; field of
view from 320 to 380 mm; data matrix size 256 × 224;
phase of field of view 0.75; trigger delay was minimum;
and views per segment 8 to 12 according to heart rate; flip
angle 45°. Thirty cine frames were obtained for each slice.
Three short axes slices, respectively at basal, middle and
distal levels and 4-, 2-, and 3-chamber views of the left
ventricle (LV), have been used for calculating regional
wall motion (WM). The basal middle and distal segments
were defined in relation to the papillary muscles; basal
segments were below and middle segments were above
the appearance of papillary muscles; middle segments
were in the presence of papillary muscles. The LV has been
divided into a 17-segment model. WM has been semi
quantitatively assessed as follows: 1 = normokinetic, 2 =
hypokinetic, 3 = akinetic and 4 = dyskinetic [21]. A dipy-
ridamole test has been considered to be positive for func-
tional criteria when wall motion worsened in 2
contiguous myocardial segments. There were 2 experi-
enced observers reading wall motion, who were blinded
to each other and to angiographic results.
Coronary angiography
Coronary angiography in multiple views was performed
according to the standard Judkins or Sones technique. At
least five views (including two orthogonal views) were
acquired for the left and at least two orthogonal views for
the right coronary arteries, respectively. Additional appro-
priate projections were obtained in case of superimposi-
tion of side branches or foreshortening of the segment of
interest. A vessel was considered to have significant
obstruction if its diameter was narrowed by 50% with
respect to the prestenosic segment. All stenotic segments
were evaluated by an automated edge detection system
providing the percent stenosis diameter.
Statistical analysis
Values are expressed as mean ± standard deviation. Pro-
portions were compared by the chi-square statistic; a
Fisher's exact test was used when appropriate. A p value
<0.05 was considered statistically significant. Calculations
of sensitivity, specificity and accuracy were performed
according to standard definitions. The 95% CIs were cal-
culated for each technique, and the individual intervals
were compared. Differences between techniques were
considered significant at the 0.05 level when 95% CI did
not overlap.
Results
The main clinical data are reported in Table 1.
Table 1: Clinical characteristics of study population
No. of patients 143
Age (years) 64 ± 9
Sex (male:female) 101/42
Family history 74 (52%)
Smoking habit 56 (39%)
Hypertension 90 (63%)
Diabetes 33 (23%)
Hypercholesterolemia 107 (75%)
History of angina 98 (67%)
Patients with CAD 88
1-vessel disease 31
2-vessel disease 33
3-vessel disease 24
CAD= coronary artery diseaseCardiovascular Ultrasound 2007, 5:47 http://www.cardiovascularultrasound.com/content/5/1/47
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Coronary angiographic results
Coronary angiography demonstrated absence or only
non-significant coronary artery disease in 55 patients and
significant coronary artery disease in 88: Of these 31 had
one vessel disease, 33 two vessel and 24 three vessel dis-
ease; left main coronary artery disease was found in 4
patients.
Stress Echocardiography results
Stress echocardiography was diagnostic in 110 patients.
Three patients had a poor acoustic window (additional
file 1), 1 had an ambiguous response, 29 had a submaxi-
mal exercise stress test, and in 4 dipyridamole was prema-
turely interrupted due to side effects and were referred to
dobutamine stress echocardiography (fig. 1). Rest WMSI
was 1.0 and peak WMSI was 1.2 ± 0.3. The test was posi-
tive in 60 (54.5%) (additional files 2 and 3). Diagnostic
ECG changes and chest pain were present during the test
in 43 (72%) and 26 (43%) patients of the 60 with a posi-
tive test result.
Stress CMR results
The subgroup of 35 patients with a non-diagnostic and/or
suboptimal stress echocardiography underwent dipyrida-
mole CMR. The test was feasible in 33 of them (1 did not
fit into the MR bore and 1 was not imaged because of anx-
iety) (fig. 1). Rest WMSI was 1.0 and peak WMSI was 1.12
± 0.2. The test was positive in 14 (42%) patients (addi-
tional files 4 and 5).
Correlation between angiographic data and stress results
Significant coronary artery disease was present in 71 of the
110 who underwent stress echocardiography and in 17 of
the 33 who underwent dipyridamole CMR. The number
of interpretable and/or maximal tests and test sensitivity
significantly increased, with only a negligible loss of spe-
cificity when the sequential model was applied (fig.2 and
3). In fact sensitivity for detecting CAD was 63% (95% CI
52% to 73%) for stress echo consecutive patients and
increased to 76% (95% CI 66% to 84%) for the sequential
model with stress CMR; specificity was 89% (95% CI 78%
to 96%) and 87% for stress CMR (95% CI 75% to 94%),
respectively. Accuracy was 73% for stress echo (95% CI
65% to 80%) and increased to 80% (95% CI 73% to 86%)
when stress CMR was employed.
Discussion
Stress CMR can be used to diagnose inducible ischemia in
patients unable to undergo stress echocardiography. Diag-
nostic accuracies of the two techniques are comparable
and the more demanding and expensive CMR can be used
as a second line technique only when stress echocardiog-
raphy is submaximal, inconclusive or unfeasible.
In fact, image quality is one of the major limitations of
stress echocardiography interpretation and this affects sig-
nificantly diagnostic accuracy [12] and wall motion anal-
ysis during CMR can overcome this limitation.
Comparison with previous studies
The results of our study are broadly consistent with several
studies suggesting that both stress echo (with exercise or
pharmacologic stress, both with dipyridamole and dob-
utamine) and CMR are excellent options for the diagnosis
of CAD [23-27]. This has also been stated in recent ESC
guidelines [2] and is in agreement with the recent ESC
panel report on the clinical use of CMR that consider
Bar graph showing sensitivity and specificity in consecutive  patients and after the sequential model with CMR as a sec- ond line stress technique has been employed Figure 3
Bar graph showing sensitivity and specificity in consecutive 
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stress MR a class II examination for the diagnosis of coro-
nary artery disease [28]. Overall, the feasibility and diag-
nostic accuracy of each test is lower than previously
reported, but this is unavoidable when one moves from
initial feasibility studies [15,26,29-31] to clinical studies
where the technique is deployed in the field on consecu-
tive, challenging and often "difficult" patients [8]. The low
sensitivity of the test may be due to several factors: All
patients had a normal baseline function; a high number
of patients were studied under anti-ischemic therapy (59
out of 152), which reduces sensitivity of wall motion; 31
out of 88 patients had a single vessel disease; Moreover we
analysed only regional wall motion for both SE and CMR,
without addition of myocardial perfusion or Coronary
flow reserve criteria. Nevertheless, the overall perform-
ance of the algorithm seemed acceptable in the "real life"
context.
Clinical implications: "nobody is perfect"
There are several tests and strategies for the evaluation of
patients with known or suspected coronary artery disease,
but no single strategy has been demonstrated to be supe-
rior overall. The clinical plausibility of this algorithm
stems from the obvious fact that "nobody is perfect", also
among stress tests, and there is the primary need to opti-
mise economic and technological resources without
reducing the standard of diagnostic excellence. In the
present study a clinical practical algorithm in which stress
echocardiography and stress CMR can be used in a
sequential way (see fig.1) for the assessment of CAD is
proposed. The 3 major aspects of the algorithm are: 1.
restrict the indication to more expensive methods to
patients really in need; 2 – to have a maximal result in all
patients, since submaximal stress test have low diagnostic
and prognostic value [19,32]; 3 – minimize long term
risks due to the use of radiation [33,34] with a radiation-
free stress imaging algorithm allowing to select for coro-
nary angiography and revascularization only patients with
a functionally significant, and therefore prognostically
malignant, forms of coronary artery disease, who are more
likely to benefit from a physiologic driven revasculariza-
tion. In this algorithm, CMR replaces cardiac stress scintig-
raphy which gives a dose exposure corresponding to 500
(with Sestamibi) to 1,600 (with Thallium or dual isotope
scan) chest x-rays per each exam [33-36]. Since 10 million
cardiac stress scintigraphies are performed each year in
US, the positive impact of our proposed algorhythm on
downstream risks would be remarkable [37,38]
Conclusion
A sequential functional stress imaging algorithm with
stress echo first and stress CMR in selected cases is feasible,
clinically realistic and allows a highly efficient, radiation-
free diagnosis of CAD in almost all patients in whom car-
diac stress imaging is clinically indicated.
Stress CMR is an excellent option when stress echocardi-
ography is inconclusive or unfeasible.
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